首页   按字顺浏览 期刊浏览 卷期浏览 Plasma free N‐terminal fibronectin 30‐kDa domain as a marker of endothelial dysfunction...
Plasma free N‐terminal fibronectin 30‐kDa domain as a marker of endothelial dysfunction in type 1 diabetes mellitus

 

作者: J. ŠKRHA,   I. VACKOVÁ,   J. KVASNIČKA,   V. STIBOR,   P. ŠTOLBA,   H. RICHTER,   H. HÖRMANN,  

 

期刊: European Journal of Clinical Investigation  (WILEY Available online 1990)
卷期: Volume 20, issue 2Part1  

页码: 171-176

 

ISSN:0014-2972

 

年代: 1990

 

DOI:10.1111/j.1365-2362.1990.tb02265.x

 

出版商: Blackwell Publishing Ltd

 

关键词: Albuminuria;diabetic microangiopathy;N‐terminal fibronectin 30‐kDa domain;von Willebrand factor

 

数据来源: WILEY

 

摘要:

AbstractThe plasma free N‐terminal fibronectin 30‐kDa domain was measured in 44 type 1 diabetic patients and in 20 healthy subjects. A significantly raised mean concentration of a free N‐terminal fibronectin 30‐kDa domain was found in plasma of diabetic patients with proliferative retinopathy as compared with healthy persons (P<0·001). A positive correlation was observed between free N‐terminal fibronectin 30‐kDa domain and von Willebrand factor in plasma of all examined subjects (r= 0·62,P<0·01). A similar correlation was present between 30‐kDa domain and albuminuria (r= 0·56,P<0·01). However, no relationship was found between fibronectin 30‐kDa domain and control of diabetes as assessed by fructosamine concentration. The free N‐terminal fibronectin 30‐kDa domain may be used as a marker of actual endothelial cell

 

点击下载:  PDF (471KB)



返 回